MH
Insider
Michael R Hayden
DirectorMichael R Hayden (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). Across 2 priced purchase filings, the average 21-session return was +14.6% from execution and +8.8% from disclosure (delay-adjusted; derived). The largest single filing was $1.1M of IONS (20,000 sh across 2 lots, as filed), executed Jul 30.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+14.6%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+8.8%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Aug 12
Filed Aug 14
Median ADV $142.4M across their filed names
Open performance→Volume by month
Buys $2.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
IONS
Ionis Pharmaceuticals, Inc.
IONS · 2 buys · 0 sells
2 filings
ABCLRecent filings
ABCLPURCHASE
AbCellera Biologics Inc.
View filing →
$481K46,387 sh × $10.37
Exec Aug 12
Filed Aug 14 · 11:50 AM ET IONSPURCHASE Ionis Pharmaceuticals, Inc. View filing → $1.1M
20,000 sh across 2 lots
Exec Jul 30
Filed Jul 31 · 4:42 PM ET IONSPURCHASE Ionis Pharmaceuticals, Inc. View filing → $478K
15,000 sh × $31.86
Exec May 1 2025
Filed May 2 2025 · 5:30 PM ET